Collateral Pharma Private Limited

Collateral Pharma Private Limited - pharma in Patna, Bihar, India. Directors, charges & compliance details.
CIN U51909BR2016PTC032188 Incorporated 03 August 2016 ROC Patna HQ Patna, Bihar, India
Struck Off Private Limited Company pharma
Data last updated
Revenue · FY 2022
₹44,064
▼ 30% YoY
Net loss · FY 2022
₹43,269
Net margin -98.2%
EBITDA · FY 2022
-₹58,471
EBITDA margin -132.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹3 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Collateral Pharma Private Limited

Data last updated:

Collateral Pharma Private Limited was a private limited company based in Patna, Bihar, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 August 2016.

The company was registered with the Registrar of Companies (ROC), Patna, under CIN U51909BR2016PTC032188. Its GSTIN is 10AAGCC6072R1ZE (Bihar).

The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh. It was led by directors Rakesh Kumar and Indu Kumari.

Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office was at Patna, Bihar.

As per the financials filed for FY 2022, the company reported a revenue of ₹44,064, a decline of 30% compared to the previous year. For the same year it recorded a net loss of ₹43,269 (net margin -98.2%) and EBITDA of -₹58,471 (EBITDA margin -132.7%). Revenue has declined at a compounded annual rate (CAGR) of 33% over three years.

Company details

CIN U51909BR2016PTC032188
Registration Number 032188
Incorporation Date 03 August 2016
ROC Patna
Listing Status Unlisted
Company Status Struck Off
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2022
Compliance Status Active Compliant

Contact details

Collateral Pharma Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    C/O Krishna Sharma 198 Abhiyanta Nagar New Bailey Road D, Anapur, Patna, Bihar, India – 801503
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Collateral Pharma Private Limited, buy the company report.

Comprehensive company report
Collateral Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Collateral Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Collateral Pharma Private Limited, buy the company report.

Financials of Collateral Pharma Private Limited

FY 2022 filings available

Collateral Pharma Private Limited reported revenue of ₹44,064 (down 30% YoY) for FY 2022.

Revenue · FY 2022
₹44,064 ▼ 30%
Net loss · FY 2022
₹43,269 margin -98.2%
EBITDA · FY 2022
-₹58,471 margin -132.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 30%
3 years · compounded
▼ 33%
EBITDA CAGR growth
1 year
▼ 71%
3 years · compounded
▼ 42%
5 years · compounded
▼ 13%

Revenue has declined at a compounded annual rate (CAGR) of 33% over three years, including a 30% fall in the latest year. EBITDA fell 71% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹58,471
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹43,269
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profitability
EBITDA Margin-132.7%
Net Profit Margin-98.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Collateral Pharma Private Limited, buy the company report.

Board of directors of Collateral Pharma Private Limited

Collateral Pharma has 2 directors on record. No former directors are listed.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Rakesh KumarDirector03 Aug 201610 Years 2 MonthsAs last reported
Indu KumariDirector03 Aug 201610 Years 2 MonthsAs last reported

Peer comparison

Collateral Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Collateral Pharma Private Limitedthis company₹44,064 (FY 2022)-₹43,269-98.2%-30.0%Patna, Bihar, India
Right Choice Care Private Limited₹42,810 (FY 2024)46.0%Lucknow, Uttar Pradesh, India
Chandra Medical Mission Private Limited₹42,730 (FY 2021)-28.0%Chennai, Tamil Nadu, India
Rescure Remedies Private Limited₹42,630 (FY 2025)-99.0%Chandigarh, India

To see the full peer comparison of Collateral Pharma Private Limited, buy the company report.

Auditor

Collateral Pharma Private Limited is audited by MK MISHRA AND ASSOCIATES for the financial year 2017.

Auditor firmFinancial yearFirm registration number
MK MISHRA AND ASSOCIATESFY 2017014406C

Shareholding

The shareholding of Collateral Pharma Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Collateral Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Collateral Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Collateral Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
10AAGCC6072R1ZEBiharActive27 Mar 2018

To see the full GST registrations and return filing status of Collateral Pharma Private Limited, buy the company report.

Recent activity

Collateral Pharma Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Indu Kumari was appointed as Director on 03 Aug 2016.

AGM
Collateral Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Filing
Collateral Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Patna.
Appointed
Indu Kumari was appointed as Director.
Appointed
Rakesh Kumar was appointed as Director.
Incorporation
03 Aug 2016
Collateral Pharma Private Limited was registered on 03 Aug 2016 with Roc Patna & aged 10 years 3 months as per MCA records.

Frequently asked questions

Collateral Pharma has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

Collateral Pharma was a private limited company based in Patna, Bihar, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 August 2016 and is registered under CIN U51909BR2016PTC032188. The company has been struck off by the Registrar of Companies and is no longer operational.

Collateral Pharma had 2 directors:

The CIN (Corporate Identification Number) of Collateral Pharma is U51909BR2016PTC032188. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Collateral Pharma is at CO Krishna Sharma 198 Abhiyanta Nagar New Bailey Road D, Anapur, Patna, Bihar, India – 801503.

Collateral Pharma was incorporated on 03 August 2016. It is registered with the Registrar of Companies, Patna.

The latest financial statements of Collateral Pharma on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2017 are in the company report.

The GSTIN of Collateral Pharma is 10AAGCC6072R1ZE, registered in Bihar.

Collateral Pharma operated in the pharma industry, in the pharmaceutical retailers and distributors segment. It worked in this industry before it was struck off.

The peers of Collateral Pharma by revenue are Right Choice Care Private Limited, Chandra Medical Mission Private Limited, Rescure Remedies Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

Indu Kumari was appointed as Director on 03 Aug 2016. Rakesh Kumar was appointed as Director on 03 Aug 2016.